chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving my 1st Pfizer dose (Lot #FE3182) on 8/31/21, which was also administered via injection/shot in my left arm, I experienced a stiff neck (unable to turn to the left without pain) a couple days after. This stiffness/pain persisted until I received my 2nd dose on 9/22/21. Within a week after receiving my 2nd dose, I started to feel tingling and numbness in my left arm and hand--whether I was standing, sitting, or laying down. The tingling and numbness is experienced 24 hours a day, 7 days a week. I also feel slight tingling/numbness in my right arm and hand, but is typically felt when laying down to sleep. In addition to the constant pain and discomfort, I experienced one extremely bad episode on 10/1/21 when I reached for an item in our kitchen cupboards and an intense, sharp, pain shot through my right hand (hand I was using to reach in the cupboard) all the way to my left hand, causing me to bend over and "collapse" in pain.  The persistent pain, coupled with that intense episode, was so excruciating and scary that I ultimately decided to see my doctor on 10/22/21. I have never experienced tingling and/or numbness in any of my limbs over the course of my entire life. After that visit, I was prescribed Gabapentin and Prednisone. I took Prednisone for a week and am continuing to take Gabapentin for pain as of today, 11/9/21.
Vaccine administration 1/7/2022. Patient reported swelling on left arm, shoulder, neck up to ear and lymph nodes starting 1/9/2022. Also reported mild swelling on right shoulder. Patient believed the injection was administered high but in deltoid. She reported to ICU on 1/12/2022. She took Benadryl 12.5mg at 3 pm on 1/12/2022. She reported swelling (not resolving) but no redness, heat or fever. This was reported to the pharmacy 1/13/2022 via telephone.
Pt had severe pain, swelling and redness at injection site, 2 days, post vax. Had 7cm round area of right deltoid and was warm to touch and swollen. Treated with Benadryl po, Atarax po and Motrin po.
Patient passed out after given the vaccine.Onsite EMS was called they woke the up vitals BP 113/63 99% O2 room air HR 84. She responed that usually happens every medical procudure or so. She was monitored. Patient treated, Left aginst medical advice.
This case was reported by a healthcare professional (nurse) via sales representative and described the occurrence of swelling injection site in a 12-month-old male subject who was vaccinated with HAVRIX pediatric (GlaxoSmithKline). Concurrent vaccination included MMR (non-gsk); non-GSK manufacturer;unknown left thigh given on 24 January 2014; varicella virus vaccine; manufacturer unspecified;unknown;right thigh given on 24 January 2014. On 24 January 2014 the subject received 1st dose of HAVRIX pediatric (unknown details, right thigh). On 2 February 2014, 9 days after vaccination with HAVRIX pediatric, the subject experienced swelling injection site and injection site redness. Per the nurse, the subject experienced swelling at the injection site that was "non-tender and about 4 centimeters (40 millimeters) in diameter." The subject sought medical attention at the emergency room on 2 February 2014 and the physician's office on 3 and 4 February 2014. The nurse considered that "it was possible" that the events were "a reaction to the aluminum in the vaccine." At the time of reporting the outcome of the events were was unspecified. The healthcare professional considered the events were possibly related to vaccination with HAVRIX pediatric.
significant vision loss; sensorineural hearing loss; Information has been received from a lawyer referring to a male patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On or around 19-NOV-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live, the patient suffered significant vision loss and sensorineural hearing loss. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events significant vision loss and sensorineural hearing loss was considered to be not recovered and causal relationship was assessed as related.    The lawyer considered the events significant vision loss and sensorineural hearing loss to be disability.  Upon internal review, significant vision loss and sensorineural hearing loss were determined to be medically significant.
No adverse effect; Administered improperly stored doses of Proquad; This spontaneous report was received from medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions or allergies were not provided. The patient's concomitant medication included sterile diluent (DILUENT MRK).  On 15-APR-2019, the patient was vaccinated with 1 dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot# R017628 (expiry date 18-DEC-2019) (frequency, strength, route, anatomical location were not provided) for prophylaxis (product storage error). The vaccine was stored at a temperature of -14 Celsius (C)  to -10 C (-11 C) for 30 minutes and also at -9 degree C to 8 degree C (-7.1 Celsius) for 45 minutes. There was no previous temperature excursion. The patient did not experience any adverse effects. The call was because of a data logger. No product quality complaint (PQC) was involved.  This is one of the several reports received from same reporter.; Sender's Comments:  US-009507513-1904USA009353: US-009507513-1904USA009840: US-009507513-1904USA009842:
pt recvd vax; devel immed pain lt deltoid;felt ill that eve;devel sz like activity;LOC,eyes rolled back, shaking of extremities;
1-11-09 fever 104F, crying all time, wouldn't lay down.  1/12/08 - ER hospital, transferred to hospital - spinal meningitis, bacterial.  Bacteria not identified.  tx - IV antibiotics.  D/cd 1/16/08 No residual effects.  Mom stated Dr. said could be from shots or eye infection.  4/1/08 Reviewed ER medical records of 01/12/08. FINAL ER DX: meningitis Records reveal patient w/fever x 4 days.  Seen by PCP, dx w/URI & tx w/oral antibiotics.  Excessive crying x 1 day whenever laid down.  Exam revealed left eye irritation, drainage & edema.  LP done.  Admitted & tx w/IV antibiotics  5/1/08 Reviewed hospital medical records of 1/12-1/16/2008. FINAL DX: meningitis Records reveal patient w/fever.  Seen by PCP & dx w/URI, tx w/antibiotics.  Fever continued, screaming/crying unconsolable.  Took to ER where admitted for febrile illness.  When LP (+), transferred to higher level of care.  On admit, had green drainage left eye w/swelling, tachycardia & poor perfusion.  Tx w/IVF & multi IV antibiotics Progressed & d/c w/home health to continue IV antibiotcs via PICC line & f/u w/PCP.
L arm cellulitis-Rx  Keflex 500 QiD< 10 days # 40 no refills
post vaccine nodule, no redness, no pain or tenderness, hard bump size of quarter at injection site immediately after receiving injection
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unspecified dates the patients were administered unspecified number of improperly stored doses of ROTATEQ (lot number K006455 - expiration date 10-FEB-2016 and lot number K004468 - expiration date 08-DEC-2016) (oral, strength and dose were unknown). No adverse event was reported. Follow up information has been received from the registered nurse on 27-JUL-2015 concerning a patient of unknown age and gender. The patient received improperly stored doses of ROTATEQ (oral, dose was unknown) on 03-APR-2015 and 26-MAY-2015, respectively. This is one of several reports received from the same reporter. Additional information has been requested. Patient's information, products, events and narrative were updated.
I felt like a hey fever attack, congestion in the head, over the next day nothing really changed. By Wednesday, I could not breathe through my nose at all, and I had a slight head ache. By Thursday, I had upper chest congestion with the head ache. On Friday, I lost my taste and smell and I went to urgent care and that is where they told me I had Covid after having a Covid test done.
Numbness. No paralysis or muscle involvement.  No signs of Bell's palsy although reported temporary numbness/tingling left face.  No signs of shingles and too many dermatomal involvement to be considered shingles Possibly related to vaccine, although symptoms started almost 3 weeks out from the covid vaccine. will start on prednisone.  Discussed potential side effects including increased sugar, weight gain, sleep issues, and GI issues Rx for prednisone given Will report to VAERS Advised not to take the second covid vaccine, currently scheduled for 4/28th.  will check cbc cmp tsh magnesium
Shooting pain up her left arm and into her neck ever since she had her Hep B vaccination this morning and that the pain is getting worse.
This is a spontaneous report from a contactable consumer. A patient of unspecified age, ethnicity, and gender received PREVNAR via an unspecified route of administration on an unspecified date at single dose. Relevant medical history and concomitant medications were not reported. The patient experienced rash on the arm, where injection was given on an unspecified date with outcome of unknown. The action taken for PREVNAR was not applicable. Follow-up (24JUL2015): Follow-up attempts completed. No further information expected.
Patient initially had a positive COVID test on 12/8/2022; He was prescribed Paxlovid 12/10/2022 and completed a 5-day course. On 12/26/2022, patient presented to the emergency department due to worsening of shortness of breath, dyspnea on exertion, and cough over the past week; He was tested for COVID on 12/26/2022 and was positive; Chest x-ray on 12/26/2022 showed severe diffuse patchy consolidation. On 12/26/2022 was negative for PE, with extensive bilateral ground glass opacities and interstitial thickening, along with bilateral hilar and mediastinal lymphadenopathy. Patient was diagnosed with COVID-19 with hypoxia, possible secondary bacterial pneumonia. He was admitted to the hospital for treatment.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.
Large red painful rash at injection site. Hot to the touch. Went to Walk In clinic to get it looked at. Pain at the site from the beginning and rash, heat, pain and itching came later.
Approximately 7 hours after receiving vaccine, I experienced severe abdominal pain.  Treated with 2, 500mg Tylenol, laid down, walked around to no avail.  Thought it might be gas pain, took 2 Tums to no avail.  Abdominal pain was increasing, was nauseous. Thought I might be experiencing a heart attack.  3/14/21Proceeded to the Hospital ER.  Arrived at 9pm, was in ER until 4:30am, after CT Scan with dye and Ultrasound of gallbladder was admitted.  Monday, 3/15/21 had a HIDA scan/exam, was scheduled for surgery to laparoscopically remove my gallbladder at 1pm Tuesday 3/16/21.
flu-like symptoms; body aches; fever; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (bad headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (bad headache). On 16-Mar-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (bad headache) had resolved.            It was reported that the patient had received Booster Dose of Moderna vaccine on 28 AUG 2021, which is 5.5 Months after the second dose of Moderna vaccine,  and he feels fine without experiencing any Adverse Events.  No concomitant medications were reported No treatment medications were reported.   This case was linked to MOD-2021-307152 (Patient Link).
Information has been received from a physician concerning a female (age unknown) with a "dreadful" fear of needles since she was a little girl, who on 15-AUG-2007 was vaccinated with a first dose of Gardasil.  Concomitant vaccinations included hepatitis A virus vaccine (unspecified), MENACTRA and ADACEL.  On 15-AUG-2007, after all doses of vaccinations were administered, the patient fainted.  The patient sought unspecified medical attention.  On 15-AUG-2007 the patient recovered and left the office after a short period of time.  No product quality complaint was involved.  Additional information has been requested.
Red mark about the size of a baseball at injection site arrived about a week after getting first dose.. Slightly itchy and warm to the touch.
I have been getting hives on a regular basis since 04/30/2021, and have been having urethral pain which started around the same time.
sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient received Shingles vaccine and experienced sickness. For tolerance of 2nd dose of Shingles vaccine, refer case US2021AMR178221, reported by the same reporter. This case has been linked to US2021AMR178143, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR178143:comment response case US-GLAXOSMITHKLINE-US2021AMR178221:Same reporter
injection site was warm; the injection was itchy; injection site grew more tender over the course of a few days; red blotch at injection the injection site developed eight days after the vaccine; injection site achy and tender to the touch approximately seven days after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy), VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine), VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine). On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine). On an unknown date, the patient experienced INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days). The patient was treated with CORTISONE for Itch, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) for Itch, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (injection site was warm), VACCINATION SITE PRURITUS (the injection was itchy), VACCINATION SITE PAIN (injection site achy and tender to the touch approximately seven days after the vaccine), VACCINATION SITE ERYTHEMA (red blotch at injection the injection site developed eight days after the vaccine) and VACCINATION SITE PAIN (injection site grew more tender over the course of a few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.
p/vax pt devel an inj site rxn characterized by a 5cm area of swelling, erythema & induration;tx w/applications of ice & DPH;pt recovered;
Within half an hour, the area around where the vaccine was injected started to swell. I had swelling the size of a grapefruit in my left arm.  It was red, hot, and distinctly sore. The next morning my fever was elevating. I called my daughter and asked if she could come home with me. I had a fever that was about 102 degrees at the highest and then 101.8. It stayed that way for an extend period of time. I was cold and hot then hot and cold. I was dizzy, nauseated, and had no appetite. I slept a lot which I usually don't do. Just going to the bathroom was a major effort. I didn't eat for a few days. I only drunk water. I was really sick. I just called the nurse hotline, and she said it was normal for people in my age group to experience those symptoms. She told me to just rest and take some Tylenol.
hair loss after receiving the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss after receiving the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss after receiving the Moderna vaccine). At the time of the report, ALOPECIA (hair loss after receiving the Moderna vaccine) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-670181, US-MODERNATX, INC.-MOD-2022-670192 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-670181:Female case 1 US-MODERNATX, INC.-MOD-2022-670192:Female case 2
TOOK FULL COURSE OF VIVOTIF WITH FOOD; This spontaneous case report was received from a nurse (PVX2019-689) on 21-Mar-2019. It described an adult female consumer who "took full course of Vivotif with food". The consumer was receiving Vivotif (one dose every other day) for typhoid prophylaxis.  It was reported that the consumer took all the doses of Vivotif with food.  The action taken with Vivotif with respect to the event "took full course of Vivotif with food" was not applicable.  The clinical outcome of the event "took full course of Vivotif with food" was unknown.  Company's Comment: The causality of the event "took full course of Vivotif with food" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took full course of Vivotif with food" was considered as not applicable.
2/16/21-NOTICED  SWOLLEN CHEST ON LEFT SIDE ALONG WITH PAINFUL AXILLARY LYMPH NODES LEFT AXILLA 3/4/21-WENT TO PREVIOUSLY SCHEDULED DR APPT AND MENTIONED TO DR. --GYNECOMASTIA LEFT SIDE. 3/11/21- ULTRASOUND AND MAMMOGRAM PERFORMED 3/12/21-NEEDLE BIOPSY COMPLETED ON LEFT SIDE OF CHEST. BIOPSY NEGATIVE. 4/14/21-BLOOD TEST FOR ABNORMAL HORMONES NEGATIVE 4/19/21-LEFT CHEST AREA STILL SWOLLEN
Bad headache; Chills; Feeling really bad; Aches; Temperature 105F; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling really bad), PAIN (Aches), PYREXIA (Temperature 105F), HEADACHE (Bad headache) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced FEELING ABNORMAL (Feeling really bad), PAIN (Aches), PYREXIA (Temperature 105F) and CHILLS (Chills). On 01-Jan-2021, the patient experienced HEADACHE (Bad headache). On 03-Jan-2021, FEELING ABNORMAL (Feeling really bad), PAIN (Aches), PYREXIA (Temperature 105F), HEADACHE (Bad headache) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2020, Body temperature: 105 °F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 04-Apr-2021: No specific follow-up information recorded.
I began with tiredness and upset stomach. I am sick as I write this so the it is possibly not very coherent. 1)extreme sore throat, almost cannot swallow 2)running nose, sneezing 3)cough 4)mild fever, I have not checked my fever unmedicated.  5)Nasal Congestion and I almost forgot the massive 6)Headaches I had when the symptoms were beginning. As well I do not know if I am contagious or not due to the fact that I got sick from the vaccine.  Please notify me.  I am taking precautions in hygiene and wearing face masks but I am not quarantined.  The nurse said I would get mildly get sick, but I slept all day yesterday and can barely move today.
Started getting dizzy / nauseous/ light headed at 11:30, extremely tired, major headache until 8pm
3RD DOSE MODERNA COVID VACCINE GIVEN 12/14/21, LOT #030H21B;  pt brought to ED via EMS after a fall at home; found to be hyperkalemic, AKI, UTI, DVT, LL extremity; developed Atrial Fibrillation with RBR; found to be positive for COVID, although asymptomatic and on RA; blood loss anemia requiring transfusion; complex medical issues; DNR; family wanted pt to be dc'd to SNF with comfort measures only; transitioned pt to CMO; plans to dc pt 10 days post COVID  positive test, but pt passed away in the hospital before going to SNF